| 产品名称: | Pseudomonas aeruginosa |
|---|---|
| 商品货号: | TS261633 |
| <strong>Name </strong>: | Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 |
| <strong>DSM No. </strong>: | 1117 dsm-1117 dsm1117 dsm 1117 Pseudomonas aeruginosa |
| Strain designation : | Boston 41501 |
| Other collection no. <br />or WDCM no. : | ATCC 27853, CCM 3955, CCUG 17619, CECT 108, CIP 76.110, JCM 6119, LMG 6395, NCIMB 12469, WDCM 00025 |
| Isolated from : | blood culture |
| Country : | country of origin unknown |
| Date of sampling : | before 31.10.1977 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | 16S rRNA gene: AB594760 |
| Cultivation conditions : | Medium 1 , 37°C or Medium 92 , 37°C or Medium 693 , 37°C Incubation time: 1-2 days Complete DSMZ Media List |
| Summary and <br />additional information : | sampling date: before 31.10.1977. Taxonomy/description (4029). Sequence accession no. 16S rRNA gene: AB594760. No growth on Oxoid Brilliance CRE agar, weak growth on Brilliance ESBL agar, . Quality control strain for media (1554), API 20 NE, quality control strain, Assay of tobramycin (4632, 4742), Quality control strain according to DIN 58959-7 (6924), Antibiotic assays and susceptibility testing according to EUCAST. (Medium 1, 37°C or Medium 92, 37°C or Medium 693, 37°C). |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 1548, 1549, 1550, 1551, 1552, 1553, 1554, 1555, 4029, 4632, 4742, 6924 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 |
| Other cultures : | All DSMZ cultures of the species |
| 产品名称: | Pseudomonas aeruginosa |
|---|---|
| 商品货号: | TS261633 |
| <strong>Name </strong>: | Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 |
| <strong>DSM No. </strong>: | 1117 dsm-1117 dsm1117 dsm 1117 Pseudomonas aeruginosa |
| Strain designation : | Boston 41501 |
| Other collection no. <br />or WDCM no. : | ATCC 27853, CCM 3955, CCUG 17619, CECT 108, CIP 76.110, JCM 6119, LMG 6395, NCIMB 12469, WDCM 00025 |
| Isolated from : | blood culture |
| Country : | country of origin unknown |
| Date of sampling : | before 31.10.1977 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | 16S rRNA gene: AB594760 |
| Cultivation conditions : | Medium 1 , 37°C or Medium 92 , 37°C or Medium 693 , 37°C Incubation time: 1-2 days Complete DSMZ Media List |
| Summary and <br />additional information : | sampling date: before 31.10.1977. Taxonomy/description (4029). Sequence accession no. 16S rRNA gene: AB594760. No growth on Oxoid Brilliance CRE agar, weak growth on Brilliance ESBL agar, . Quality control strain for media (1554), API 20 NE, quality control strain, Assay of tobramycin (4632, 4742), Quality control strain according to DIN 58959-7 (6924), Antibiotic assays and susceptibility testing according to EUCAST. (Medium 1, 37°C or Medium 92, 37°C or Medium 693, 37°C). |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 1548, 1549, 1550, 1551, 1552, 1553, 1554, 1555, 4029, 4632, 4742, 6924 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 |
| Other cultures : | All DSMZ cultures of the species |